A heterozygote phenotype is present in the jvs +/− mutant mouse livers
- 31 May 2002
- journal article
- Published by Elsevier BV in Molecular Genetics and Metabolism
- Vol. 76 (1), 76-80
- https://doi.org/10.1016/s1096-7192(02)00017-3
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Consequences of Complexity within Biological Networks: Robustness and Health, or Vulnerability and DiseaseMolecular Genetics and Metabolism, 2001
- Synergistic Heterozygosity: Disease Resulting from Multiple Partial Defects in One or More Metabolic PathwaysMolecular Genetics and Metabolism, 2000
- A Variable Myopathy Associated with Heterozygosity for the R503C Mutation in the Carnitine Palmitoyltransferase II GeneMolecular Genetics and Metabolism, 2000
- Loss of wild-type carrier-mediatedL-carnitine transport activity in hepatocytes of juvenile visceral steatosis miceHepatology, 1999
- cDNA Sequence, Transport Function, and Genomic Organization of Human OCTN2, a New Member of the Organic Cation Transporter FamilyBiochemical and Biophysical Research Communications, 1998
- Mitochondrial Abnormalities in a Murine Model of Primary Carnitine DeficiencyEuropean Neurology, 1997
- Primary defect of juvenile visceral steatosis (jvs) mouse with systemic carnitine deficiency is probably in renal carnitine transport systemBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1994
- Animal model of systemic carnitine deficiency: Analysis in C3H-H-2° strain of mouse associated with juvenile visceral steatosisBiochemical and Biophysical Research Communications, 1991
- Successful Carnitine Treatment in Two Siblings Having Lipid Storage Myopathy with Hypertrophic CardiomyopathyNeuropediatrics, 1985
- Systemic Carnitine Deficiency Presenting as Familial Endocardial FibroelastosisNew England Journal of Medicine, 1981